Letters
Breast cancer and hormonal supplements in postmenopausal women
Benefits probably outweigh risksEDITOR,--Hormone replacement therapy can undoubtedly alleviate the distressing symptoms associated with the menopause, and most research indicates that, in the short term at least, it is safe. Many women feel healthier and more vivacious when taking hormone replacement therapy and wish to continue it long term, and there is evidence that prolonged treatment is associated with a reduction in mortality and morbidity from degenerative disease of the cardiovascular and skeletal systems.
We must, however, balance the benefits
against possible risks. For a 50year old woman the lifetime risk of dying of coronary heart disease may be more than five times that of dying of breast cancer, but it is the fear of breast cancer that concerns women most. We need to look at epidemiological evidence as it unfolds, and the editorial by Klim McPherson is a welcome update of the situation.1 The latest publication from the
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Breast cancer and hormonal supplements in postmenopausal women
- Klim McPherson
BMJ 1995 311: 699-700.[Extract] [Full Text]
This Article
- Full text
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Related Content
-
Breast cancer
-
Menopause (including HRT)
-
Drugs: endocrine system
-
Reproductive medicine
-
Sexual health
- Relevant Article
- Find this article in its weekly table of contents
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
